It was reported a decrease on INNOVUS PHARMACEUTICALS INC (OTCMKTS:INNV)’s shares shorted with 73.33%. In January was published INNV’s total 1,200 shares shorted by FINRA. Previously was reported down change of 73.33% from 4,500 shares.

Ticker’s shares touched $0.053 during the last trading session after 1.85% change.Currently Innovus Pharmaceuticals, Inc. is after 0.00% change in last January 28, 2018. INNV has also 86,666 shares volume. The stock the S&P 500 by 0.00%.

Innovus Pharmaceuticals, Inc., a pharmaceutical company, engages in the commercialization, licensing, and development of non-prescription medicine and consumer care products in the United States.The company has $12.98 million market cap. The Company’s products include Zestra, a proprietary blend of essential oils to enhance desire, arousal, and satisfaction in women; EjectDelay, an over-the-counter monograph-compliant benzocaine gel for premature ejaculation; Sensum+, a non-medicated cream that enhances penile sensitivity; Zestra Glide, a water longer lasting lubricant; Vesele, a proprietary oral supplement of Arginine sexual and cognitive functions; and Androferti, a natural supplement to support overall male reproductive health and sperm quality.Currently it has negative earnings. The firm also offers Beyond Human testosterone booster, Ketones, krill oil, Omega 3 fish oil, Vision Formula, blood sugar, colon cleanse, green coffee extract, and growth agent; RecalMax for brain health; and UriVarx, a proprietary supplement for overactive bladder and urinary incontinence.

For more Innovus Pharmaceuticals, Inc. (OTCMKTS:INNV) news published briefly go to:,,, or The titles are as follows: “Innovus Pharma merges with Novalere FP, nabs rights to steroid nasal spray – Seeking Alpha” published on February 05, 2015, “Innovus Pharmaceuticals (INNV) Investor Presentation – Slideshow – Seeking Alpha” on June 19, 2017, “Innovus Pharma expands into CBD oil-based products market – Seeking Alpha” with a publish date: October 18, 2018, “Innovus Pharma’s UriVarx shows positive effect in overactive bladder study – Seeking Alpha” and the last “Innovus Pharmaceuticals announces $3.17M private placement – Innovus Pharmaceuticals, Inc. (OTCMKTS:INNV) – Seeking Alpha” with publication date: December 31, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.